Dennis Elias Saadeh

This inventor holds 16 USPTO granted patents and 27 published patent applications, plus 2 CIPO patents and 1 EPO patent. Top assignees: Harrow IP, LLC, Imprimis Pharmaceuticals, Inc., Melt Pharmaceuticals, Inc.. Active years: 2018-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dennis Elias Saadeh. Retrieved from https://idiyas.com/inventor/dennis-elias-saadeh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 16 (Patent Applications = 27)

% Patents Active = 100.0

CIPO Patents = 2 (Patent Applications = 7)

EPO Patents = 1 (Patent Applications = 15)

Average Co-Inventor Count = 2.1

ph-index = 2

Forward Citations = 21(Granted Patents)

Location History:

San Diego, CA (US) (2019)
Nashville, TN (US) (2022 - 2023)
Irvine, CA (US) (2018 - 2024)
Brentwood, TN (US) (2024)

Company Filing History:

Imprimis Pharmaceuticals, Inc.

patents

3 out of 3

Melt Pharmaceuticals, Inc.

patents

4. 2 out of 4

Surface Ophthalmics, Inc.

6. 1 out of 834,570

Other

patents

Years Active: 2018-2026

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12702651 - Epinephrine-based ophthalmic compositions for intraocular administration and methods for fabricating thereof (2026-08-11),

2. 12594351 - Methods for increasing shelf-life of ophthalmic pharmaceutical compositions (2026-04-07),

3. 12083126 - Pharmaceutical compositions and methods for anesthesiological applications (2024-09-10),

4. 12070442 - Ophthalmic pharmaceutical compositions and methods for treating ocular surface disease (2024-08-27),

5. 11766421 - Ophthalmic pharmaceutical compositions and methods for treating ocular surface disease (2023-09-26),

6. 11534481 - Adrenocorticotropic hormone-based pharmaceutical formulations and methods for fabricating and using thereof (2022-12-27),

7. 11338018 - Adrenocorticotropic hormone-based pharmaceutical formulations and methods for fabricating and using thereof (2022-05-24),

8. 11266615 - Pyrimethamine-based pharmaceutical compositions and methods for fabricating thereof (2022-03-08),

9. 10660891 - Pyrimethamine-based pharmaceutical compositions and methods for fabricating thereof (2020-05-26),

10. 10555952 - Pharmaceutical compositions and methods for anesthesiological applications (2020-02-11),

11. 10426744 - Anti-fungal compositions for treating nails and methods for fabricating and using thereof (2019-10-01),

12. 10391102 - Pharmaceutical compositions and methods for anesthesiological applications (2019-08-27),

13. 10383875 - Pharmaceutical formulations of xanthine or xanthine derivatives, and their use (2019-08-20),

14. 10179136 - Pharmaceutical compositions and methods for anesthesiological applications (2019-01-15),

15. 10166240 - Pharmaceutical compositions and methods for anesthesiological applications (2019-01-01),

Title: Dennis Elias Saadeh: Innovating in Pharmaceuticals

Introduction

Dennis Elias Saadeh is a notable figure in the pharmaceutical sector based in the United States. Currently working with Imprimis Pharmaceuticals, Inc., he contributes to the innovative landscape of drug development and delivery. While he currently holds no patents, his work is vital in shaping next-generation pharmaceuticals.

Latest Patents

As of now, Dennis does not have any patents registered under his name. However, his role in a prominent company like Imprimis Pharmaceuticals positions him at the forefront of pharmaceutical innovation and development.

Career Highlights

Dennis's career has been marked by significant contributions to pharmaceutical research and development. His expertise and dedication at Imprimis Pharmaceuticals, Inc. showcase his commitment to improving patient care through innovative solutions. His work with this leading company demonstrates a focus on addressing complex medical needs and enhancing drug delivery methods.

Collaborations

In his professional journey, Dennis has collaborated with various talented individuals, including John Berdahl and William F. Wiley. These collaborations likely enhance the innovative capabilities within Imprimis Pharmaceuticals, as teamwork fosters the development of groundbreaking pharmaceutical solutions.

Conclusion

In summary, Dennis Elias Saadeh plays an essential role in the pharmaceutical industry through his work at Imprimis Pharmaceuticals, Inc. While he does not yet hold patents, his collaborative spirit and dedication to innovation suggest a promising future filled with potential contributions to medical science. His journey in pharmaceuticals exemplifies the importance of teamwork and creative thinking in addressing the challenges of healthcare.

Profile summary based on public USPTO records.